{"id":1662,"date":"2012-05-31T22:58:40","date_gmt":"2012-05-31T21:58:40","guid":{"rendered":"https:\/\/tris.sambrownprojects.com\/tris-pharma-announces-approval-of-first-ever-generic-to-delsym-dextromethorphan-polistirex-extended-release-suspension\/"},"modified":"2023-08-23T15:06:41","modified_gmt":"2023-08-23T14:06:41","slug":"tris-pharma-announces-approval-of-first-ever-generic-to-delsym-dextromethorphan-polistirex-extended-release-suspension","status":"publish","type":"post","link":"https:\/\/www.trispharma.com\/tris-pharma-announces-approval-of-first-ever-generic-to-delsym-dextromethorphan-polistirex-extended-release-suspension\/","title":{"rendered":"Tris Pharma Announces Approval of First-Ever Generic to Delsym<sup>\u00ae<\/sup> Dextromethorphan Polistirex Extended-Release Suspension"},"content":{"rendered":"<p class=\"newsHeadline\">MONMOUTH JUNCTION, N.J., May 31; \/PRNewswire\/ &#8212; Tris Pharma, a technology driven specialty pharmaceutical company announced today that the US Food and Drug Administration (FDA) has approved the first-ever generic to Delsym<sup>\u00ae<\/sup>, an extended-release oral liquid suspension containing dextromethorphan polistirex.<\/p>\n<p>Delsym was approved in 1982 and there has never been any generic alternative approved until now. Tris has pioneered the delivery of drugs in taste-neutral, extended release dosage forms such as liquids, ODT\/chewable tablets, and strips that are otherwise associated with immediate release. Tris\u2019 versatile, patented technology avoids the use of toxic organic solvents by employing aqueous-based coating.<\/p>\n<p>\u201cThis is the third extended-release liquid product approved by the FDA based on our patented technology, and speaks to Tris\u2019 capabilities to develop and commercialize difficult products\u201d said Ketan Mehta, President &amp; CEO of Tris Pharma. \u201cLeveraging our technology, Tris has built a robust and deep pipeline of unique products that will address many of today\u2019s unmet needs.&#8221;<\/p>\n<p>Perrigo is Tris\u2019 exclusive partner in distributing this product as a store-brand alternative to Delsym, and has announced that it will be shipping the product for the coming cough\/cold\/flu season. Annual sales across the entire Delsym brand are estimated at more than $100 million.<\/p>\n<p>Delsym is a registered trademark of Reckitt Benckiser, which is not associated with Tris Pharma or Tris\u2019 generic product.<\/p>\n<p><strong><u>About Tris Pharma:<\/u><\/strong><\/p>\n<p>Tris Pharma is a specialty pharmaceutical company focused on the research and development of technologies driven products. Tris has pioneered the delivery of sustained release in the liquid, chewable\/ODT and strip dosage forms so patients do not have to swallow a pill. Tris&#8217; Nobuse technology provides abuse deterrence for opioids and other abuse-prone drugs. Tris&#8217; R&amp;D and manufacturing facilities are located in Monmouth Junction, New Jersey, USA. For more information, please visit\u00a0<a href=\"\/\">https:\/\/www.trispharma.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MONMOUTH JUNCTION, N.J., May 31; \/PRNewswire\/ &#8212; Tris Pharma, a technology driven specialty pharmaceutical company announced today that the US Food and Drug&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":"","_wp_rev_ctl_limit":""},"categories":[30],"tags":[],"class_list":["post-1662","post","type-post","status-publish","format-standard","hentry","category-generics"],"acf":[],"featured_image_src":{"landsacpe":false,"list":false,"medium":false,"full":false},"yoast_head":"\n<title>Tris Pharma Announces Approval of First-Ever Generic to Delsym\u00ae Dextromethorphan Polistirex Extended-Release Suspension - Tris Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.trispharma.com\/tris-pharma-announces-approval-of-first-ever-generic-to-delsym-dextromethorphan-polistirex-extended-release-suspension\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tris Pharma Announces Approval of First-Ever Generic to Delsym\u00ae Dextromethorphan Polistirex Extended-Release Suspension - Tris Pharma\" \/>\n<meta property=\"og:description\" content=\"MONMOUTH JUNCTION, N.J., May 31; \/PRNewswire\/ -- Tris Pharma, a technology driven specialty pharmaceutical company announced today that the US Food and Drug...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.trispharma.com\/tris-pharma-announces-approval-of-first-ever-generic-to-delsym-dextromethorphan-polistirex-extended-release-suspension\/\" \/>\n<meta property=\"og:site_name\" content=\"Tris Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2012-05-31T21:58:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-23T14:06:41+00:00\" \/>\n<meta name=\"author\" content=\"rajeshlohakare@sambrown.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"rajeshlohakare@sambrown.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.trispharma.com\/tris-pharma-announces-approval-of-first-ever-generic-to-delsym-dextromethorphan-polistirex-extended-release-suspension\/\",\"url\":\"https:\/\/www.trispharma.com\/tris-pharma-announces-approval-of-first-ever-generic-to-delsym-dextromethorphan-polistirex-extended-release-suspension\/\",\"name\":\"Tris Pharma Announces Approval of First-Ever Generic to Delsym\u00ae Dextromethorphan Polistirex Extended-Release Suspension - Tris Pharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.trispharma.com\/#website\"},\"datePublished\":\"2012-05-31T21:58:40+00:00\",\"dateModified\":\"2023-08-23T14:06:41+00:00\",\"author\":{\"@id\":\"https:\/\/www.trispharma.com\/#\/schema\/person\/a23b5071b857390e7221beef1ae32be2\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.trispharma.com\/tris-pharma-announces-approval-of-first-ever-generic-to-delsym-dextromethorphan-polistirex-extended-release-suspension\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.trispharma.com\/tris-pharma-announces-approval-of-first-ever-generic-to-delsym-dextromethorphan-polistirex-extended-release-suspension\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.trispharma.com\/tris-pharma-announces-approval-of-first-ever-generic-to-delsym-dextromethorphan-polistirex-extended-release-suspension\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.trispharma.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tris Pharma Announces Approval of First-Ever Generic to Delsym\u00ae Dextromethorphan Polistirex Extended-Release Suspension\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.trispharma.com\/#website\",\"url\":\"https:\/\/www.trispharma.com\/\",\"name\":\"Tris Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.trispharma.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.trispharma.com\/#\/schema\/person\/a23b5071b857390e7221beef1ae32be2\",\"name\":\"rajeshlohakare@sambrown.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.trispharma.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/83cec6f9d7f6fd867342a65ffe372ccb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/83cec6f9d7f6fd867342a65ffe372ccb?s=96&d=mm&r=g\",\"caption\":\"rajeshlohakare@sambrown.com\"},\"sameAs\":[\"http:\/\/tris.sambrownprojects.com\"],\"url\":\"https:\/\/www.trispharma.com\/author\/rajeshlohakaresambrown-com\/\"}]}<\/script>\n","yoast_head_json":{"title":"Tris Pharma Announces Approval of First-Ever Generic to Delsym\u00ae Dextromethorphan Polistirex Extended-Release Suspension - Tris Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.trispharma.com\/tris-pharma-announces-approval-of-first-ever-generic-to-delsym-dextromethorphan-polistirex-extended-release-suspension\/","og_locale":"en_GB","og_type":"article","og_title":"Tris Pharma Announces Approval of First-Ever Generic to Delsym\u00ae Dextromethorphan Polistirex Extended-Release Suspension - Tris Pharma","og_description":"MONMOUTH JUNCTION, N.J., May 31; \/PRNewswire\/ -- Tris Pharma, a technology driven specialty pharmaceutical company announced today that the US Food and Drug...","og_url":"https:\/\/www.trispharma.com\/tris-pharma-announces-approval-of-first-ever-generic-to-delsym-dextromethorphan-polistirex-extended-release-suspension\/","og_site_name":"Tris Pharma","article_published_time":"2012-05-31T21:58:40+00:00","article_modified_time":"2023-08-23T14:06:41+00:00","author":"rajeshlohakare@sambrown.com","twitter_card":"summary_large_image","twitter_misc":{"Written by":"rajeshlohakare@sambrown.com","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.trispharma.com\/tris-pharma-announces-approval-of-first-ever-generic-to-delsym-dextromethorphan-polistirex-extended-release-suspension\/","url":"https:\/\/www.trispharma.com\/tris-pharma-announces-approval-of-first-ever-generic-to-delsym-dextromethorphan-polistirex-extended-release-suspension\/","name":"Tris Pharma Announces Approval of First-Ever Generic to Delsym\u00ae Dextromethorphan Polistirex Extended-Release Suspension - Tris Pharma","isPartOf":{"@id":"https:\/\/www.trispharma.com\/#website"},"datePublished":"2012-05-31T21:58:40+00:00","dateModified":"2023-08-23T14:06:41+00:00","author":{"@id":"https:\/\/www.trispharma.com\/#\/schema\/person\/a23b5071b857390e7221beef1ae32be2"},"breadcrumb":{"@id":"https:\/\/www.trispharma.com\/tris-pharma-announces-approval-of-first-ever-generic-to-delsym-dextromethorphan-polistirex-extended-release-suspension\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.trispharma.com\/tris-pharma-announces-approval-of-first-ever-generic-to-delsym-dextromethorphan-polistirex-extended-release-suspension\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.trispharma.com\/tris-pharma-announces-approval-of-first-ever-generic-to-delsym-dextromethorphan-polistirex-extended-release-suspension\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.trispharma.com\/"},{"@type":"ListItem","position":2,"name":"Tris Pharma Announces Approval of First-Ever Generic to Delsym\u00ae Dextromethorphan Polistirex Extended-Release Suspension"}]},{"@type":"WebSite","@id":"https:\/\/www.trispharma.com\/#website","url":"https:\/\/www.trispharma.com\/","name":"Tris Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.trispharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.trispharma.com\/#\/schema\/person\/a23b5071b857390e7221beef1ae32be2","name":"rajeshlohakare@sambrown.com","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.trispharma.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/83cec6f9d7f6fd867342a65ffe372ccb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/83cec6f9d7f6fd867342a65ffe372ccb?s=96&d=mm&r=g","caption":"rajeshlohakare@sambrown.com"},"sameAs":["http:\/\/tris.sambrownprojects.com"],"url":"https:\/\/www.trispharma.com\/author\/rajeshlohakaresambrown-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/posts\/1662"}],"collection":[{"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/comments?post=1662"}],"version-history":[{"count":1,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/posts\/1662\/revisions"}],"predecessor-version":[{"id":1762,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/posts\/1662\/revisions\/1762"}],"wp:attachment":[{"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/media?parent=1662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/categories?post=1662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/tags?post=1662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}